A prospective randomized comparison of protracted infusional 5-fluorouracil with or without weekly bolus cisplatin in metastatic colorectal carcinoma. A mid-atlantic oncology program study
- 1 January 1991
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer.Journal of Clinical Oncology, 1990
- Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group.Journal of Clinical Oncology, 1989
- Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.Journal of Clinical Oncology, 1989
- A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.Journal of Clinical Oncology, 1989
- A phase I clinical trial of combined fluoropyrimidines with leucovorin in a 14-day infusion. Demonstration of biochemical modulationCancer, 1989
- Cisplatin + 5-fluorouracil versus 5-fluorouracil alone in advanced colorectal cancer: a randomized studyEuropean Journal of Cancer and Clinical Oncology, 1988
- Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagusThe Annals of Thoracic Surgery, 1988
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958